Tuesday, July 30 10 a.m. - 10:20 a.m. Exhibit Hall Theater #2 Sponsored by Fortis Life Sciences
While molecular diagnostic assays are now common in clinical labs, their broader implementation for point-of-care testing use has been limited by assay complexity and requirement for cold chain storage. The use of lyophilized assay components can help overcome these challenges, providing simplified workflows and ambient temperature stability. Though lyophilized mixes are available for several kinds of molecular assays, the chemistries offered are typically limited to a single assay type and detection platform. Here we demonstrate the utility of single-reaction lyophilized beads, which can be custom-formulated and packaged to accommodate a wide range of assays and point-of-care devices across the diagnostic industry.
Brendan Looyenga Development Scientist, Fortis Life Sciences
Be the first to get all the latest news.